Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries

Plain language summary

“Age, disease duration, sex and other common factors may predict which patients with psoriatic arthritis achieve inactive disease when treated with TNF inhibitors”

Plain language summary of the scientific publication from EuroSpA: “Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries” by Linde, Ørnbjerg, Georgiadis et. al.

You can read the original article published in Seminars in Arthritis and Rheumatism in 2022 here: https://doi.org/10.1093/rheumatology/kead284